ONZ.L Share News (ONZ)

Onzima Ventures agrees to buy remaining 51% of N4 Pharma

(ShareCast News) - AIM-listed Onzima Ventures has agreed in principle to buy the 51% of N4 Pharma it does not already own. The consideration for the acquisition, will be classified as a reverse takeover under AIM rules, will be satisfied by the issue of just over 36.4m new ordinary shares of 0.1p ea

Onzima Ventures Investee Company N4 Pharma Files Reformulation Patents

UK Shareholder Meetings Calendar - Next 7 Days

Onzima Ventures highlights cancer vaccine potential in N4 Pharma vector

(ShareCast News) - Ozima Ventures said its 49%-owned N4 Pharma has produced encouraging initial research about the versatility and durability of its vector technology that could make it suitable for delivering anti-cancer vaccines and other therapies. Initial research findings by a University of Que

Onzima Ventures Raises GBP150,000 In Share Subscription (ALLISS)

Onzima disposes of short MX Oil investment

(ShareCast News) - Onzima Ventures disposed of its 20 million ordinary shares in MX Oil on Monday, making a net gain of £10,176 or 6.8% in the process since investing in March. The AIM-traded company retained four million warrants exercisable at 1p per share for a period of three years. "Pursuant t

Onzima Sells Its Shares In MX Oil At Gain On March Investment (ALLISS)

Onzima's N4 Pharma adds new vaccine particle to nanoparticle vector offering

(ShareCast News) - One of Onzima Ventures' investee companies has secured an improved deal with the University of Queensland for joint research into cancer drug delivery systems. The Australia university's commercialisation company, UniQuest, has agreed to give N4 Pharma, of which Onzima owns 49%, e

Onzima Says N4 Pharma Extends Rights Deal To Include Messenger RNA

UPDATE: Jubilee Platinum Secures Funding For Two Projects (ALLISS)

MX Oil raises £2.5m ahead of Nigeria deal

(ShareCast News) - MX Oil shored up its available funds as it prepared for a quick-turnaround transaction in Nigeria on Monday, announcing the successful raising of £2.5m via a placing of 333,333,333 ordinary shares and 66,666,667 warrants over ordinary shares. The AIM-traded oil and gas investing c

UPDATE: MX Oil Raises GBP2.5 Million To Cover Nigerian Payment (ALLISS)

Onzima Ventures bounces further on N4 Pharma patent deal

(ShareCast News) - Onzima Ventures' recent investment in drug reformulations outfit N4 Pharma has paid off again as N4 acquired rights to cherry-pick the best of a wide ranging portfolio of drugs rights. N4, in which Onzima took a 49% stake on 1 March, has acquired the exclusive global rights to eva

N4 Pharma acquires range of drug formulation patents

(ShareCast News) - N4 Pharma expanded its IP portfolio on Friday, its part-owner Onzima Ventures reported, acquiring the exclusive global rights to a range of patents from Opal IP, for new uses and formulations of a number of off-patent and soon to be off-patent drugs. In addition, Opal entered into

Onzima Ventures Investee Company N4 Pharma Expands Patent Portfolio